BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,775 | +51.4% | 3,358 | +50.6% | 0.01% | 0.0% |
| Q2 2023 | $15,699 | +51.6% | 2,230 | +79.5% | 0.01% | +66.7% |
| Q1 2023 | $10,358 | -70.2% | 1,242 | -59.0% | 0.00% | -75.0% |
| Q4 2022 | $34,796 | +216.3% | 3,031 | +180.1% | 0.01% | +71.4% |
| Q2 2022 | $11,000 | -15.4% | 1,082 | +31.8% | 0.01% | 0.0% |
| Q1 2022 | $13,000 | +44.4% | 821 | +20.2% | 0.01% | +75.0% |
| Q4 2021 | $9,000 | -10.0% | 683 | -5.1% | 0.00% | -33.3% |
| Q3 2021 | $10,000 | -41.2% | 720 | -32.5% | 0.01% | -45.5% |
| Q2 2021 | $17,000 | +240.0% | 1,066 | +112.8% | 0.01% | +37.5% |
| Q1 2021 | $5,000 | – | 501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |